Summary: In 58 adults with obesity (BMI 30.0 to 39.9), a 6-month randomized sub-analysis compared the multicomponent Weight Loss Maintenance 3 Phases Program (WLM3P) against a standard low-carbohydrate diet (LCD). The WLM3P arm showed a significant rise in gut alpha-diversity (p = 0.03) and a significant beta-diversity shift (p < 0.01), and higher Faecalibacterium abundance was associated with greater fat-mass and visceral-adiposity loss (p < 0.01). The design demonstrates microbial shifts and associations, not proven causal weight loss driven by gut bacteria.
PICO Summary
| Element | Detail |
|---|---|
| Population | 58 adults with obesity (BMI 30.0 to 39.9 kg/m squared); sub-analysis of a randomized controlled trial (NCT04192357); Portugal. |
| Intervention | WLM3P (n = 29): a multicomponent program combining caloric restriction, a high-protein low-carbohydrate diet, 10-hour time-restricted eating, prebiotic and phytochemical supplementation, and digital app-based support; 6-month weight-loss phase (Phases 1 and 2). |
| Comparison | Standard low-carbohydrate diet alone (n = 29), without the additional program components or digital support. |
| Outcome | Stool 16S rRNA sequencing at baseline and 6 months. WLM3P showed a significant increase in alpha-diversity (p = 0.03) and a significant beta-diversity change (p < 0.01); no significant microbiota change was seen with LCD. Higher Faecalibacterium abundance was associated with greater reductions in fat mass and visceral adiposity in WLM3P versus LCD (p < 0.01). Associations were derived from regression models; no 95% CI, effect size, or NNT was reported for the microbiota-outcome links, and no between-arm causal weight-loss difference was tested for the bacterium itself. |
Expert Commentary
This sub-analysis is best read as hypothesis-generating rather than practice-changing. A genuine signal was observed: the multicomponent WLM3P arm produced measurable gut microbiota shifts that the low-carbohydrate comparator did not, and greater Faecalibacterium abundance tracked with greater fat-mass and visceral loss. What cannot be inferred is causation. Because WLM3P bundles caloric restriction, macronutrient change, time-restricted eating, supplementation, and app support, the microbial changes cannot be attributed to any single component, and the title question is not answered by these data. The reported associations are correlational, drawn from regression within a modest sample of 58 participants, and were presented without confidence intervals or effect sizes, which limits how confidently the magnitude can be judged. The dominant limitation is therefore confounding by the intervention bundle: a shift in Faecalibacterium may be a marker of dietary change rather than its mediator. Can I use this with my patients? Not yet. There is no actionable target here, no probiotic to prescribe, and no evidence that manipulating Faecalibacterium independently aids weight loss. What it does support is continued counselling toward structured, fibre-rich, lower-carbohydrate eating, with microbiota benefit as a plausible bonus rather than a goal. Future work should isolate which program element drives the microbial shift and test whether that shift independently predicts outcomes.
References
Pereira V, Cuevas-Sierra A, de la O V, Salvado R, Barreiros-Mota I, Castela I, et al. Gut Microbiota Shifts After a Weight Loss Program in Adults with Obesity: The WLM3P Study. Nutrients. 2025;17(14):2360. doi:10.3390/nu17142360
